Pyrazolines are well-known and important nitrogen containing five-membered heterocyclic compounds with biological and pharmacological activities such as analgesic properties (Sahu et al., 2008). As part of our investigations of this area,
In the title compound, C 37 H 30 N 4 OÁC 4 H 8 O 2 , the dihedral angle between the pyrazole and dihydropyrazole rings is 74.09 (10) . In the crystal, the components are linked into centrosymmetric tetramers (two main molecules and two solvent molecules) by C-HÁ Á ÁO hydrogen bonds. C-HÁ Á Á and -[shortest centroid-centroid separation = 3.6546 (9) Å ] interactions are also observed.
Related literature
For the biological and pharmacological activity of pyrazolines, see, for example: Sahu et al. (2008) . For ring conformations, see: Cremer & Pople (1975) . For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ).
Cg1, Cg3 and Cg5 are the centroids of the N1/N2/C7/C14/C16, C1-C6 and C32-C37 rings, respectively. Symmetry codes: (i) Àx þ 1; Ày þ 1; Àz; (ii) Àx þ 2; Ày þ 1; Àz; (iii) x þ 1; y þ 1; z; (iv) Àx þ 2; Ày þ 2; Àz þ 1. we have synthesized the title compound to study its crystal structure (Fig. 1) .
The solvent 1,4-dioxane ring (O2/O3/C39-C42) adopts a chair conformation (Cremer & Pople, 1975) with puckering parameters Q= 0.567 (2) Å, Θ= 179.0 (2)° and Φ= 302 (6)°. The ring A (N1/N2/C7/C14/C16), B (N3/N4/C17/C24/C25), The crystal structure is shown in Fig. 2 . The molecules are linked into centrosymmetric tetramers (two main molecules and two solvent molecules) via C14-H14A···O2 and C41-H41B···O1 hydrogen bonds (Table 1) . C-H···π interactions (Table 1) and π···π interactions of Cg2···Cg1 = 3.6546 (9) Å (symmetry code: x,y,z) and Cg2···Cg4 = 3.7773 (10) Å (symmetry code: 2-x,1-y,-z) further stabilized the crystal structure. [Cg1, Cg2 , Cg3, Cg4 and Cg5 are the centroids of the N1/N2/C7/C14/C16, N3/N4/C17/C24/C25, C1-C6, C26-C31 and C32-C37 rings, respectively].
A mixture of (E)-1-(biphenyl-4-yl)-3-(3-(4-methoxyphenyl)-1-phenyl-1 H-pyrazol-4-yl)prop-2-en-1-one (0.456 g, 1.0 mmol) and phenylhydrazine (0.162 g, 1.5 mmol) was refluxed in glacial acetic acid for 4 h. The mixture was then cooled to room temperature and resulting solid was filtered and dried to get title compound. Yield: 0.31 g, 56.77%. M.p.: 437-439 K. 1,4-Dioxane was used as crystallization solvent to yield colourless plates.
Refinement
The H atoms were positioned geometrically [C-H = 0.95-0.99 Å] and refined using a riding model with U iso (H) = 1.2 or 1.5 U eq (C). A rotating group model was applied to the methyl group. 
Computing details

Figure 1
The molecular structure of the title compound, showing 30% probability displacement ellipsoids. 
